{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:09:34Z","timestamp":1780556974269,"version":"3.54.1"},"reference-count":211,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle and Nerve"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), multifocal motor neuropathy (MMN), and anti\u2013myelin\u2010associated glycoprotein (anti\u2010MAG) neuropathy are three demyelinating acquired neuropathies, with distinct responses to immunotherapy. In placebo\u2010controlled, double\u2010blind, randomized trials, intravenous immunoglobulin (IVIg) has been effective for CIDP and MMN, and plasmapheresis has been effective for CIDP. Corticosteroids have been beneficial in controlled trials for CIDP. Other agents, including cyclophosphamide, rituximab, azathioprine, cyclosporine, interferons, fludarabine, mycophenolate mofetil, and etanercept, have been reported to benefit some patients with inflammatory demyelinating neuropathies in case series and case reports. This review examines the use and toxicity associated with these immunotherapy medications in treating patients with chronic immune\u2010mediated demyelinating neuropathies. Muscle Nerve, 2009<\/jats:p>","DOI":"10.1002\/mus.21277","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T15:42:22Z","timestamp":1237477342000},"page":"563-578","source":"Crossref","is-referenced-by-count":70,"title":["Current treatments of chronic immune\u2010mediated demyelinating polyneuropathies"],"prefix":"10.1002","volume":"39","author":[{"suffix":"III","given":"Thomas H.","family":"Brannagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,19]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)01389-X"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.128694"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90385-G"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.3_Part_1.429"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520440064022"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6606.1141"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201233260413"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2007.00129.x"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21073"},{"key":"e_1_2_11_13_2","unstructured":"Berlex Inc.Genzyme and Schering AG announce interim results from trial of Campath for multiple sclerosis[press release];2006."},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412153312402"},{"key":"e_1_2_11_16_2","first-page":"S90","article-title":"Assessment of IVIg efficacy in chronic inflammatory demyelinating polyneuropathy using posturography: a pilot study","volume":"28","author":"Black K","year":"2003","journal-title":"Muscle Nerve"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90563-V"},{"key":"e_1_2_11_18_2","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1182\/blood.V95.5.1856.005k03_1856_1861","article-title":"Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet\u2010activating factor acetylhydrolase","volume":"95","author":"Bleeker WK","year":"2000","journal-title":"Blood"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.8.1577"},{"key":"e_1_2_11_20_2","first-page":"291","article-title":"Intravenous immunoglobulin\u2010induced neutropenia","volume":"36","author":"Bower LR","year":"1994","journal-title":"Ann Neurol"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.12_suppl_6.S33"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20524"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.3.674"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.12.1856"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.10041"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2004.00911.x"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-12-199812150-00007"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-7-200110020-00006"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90112-4"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602273140907"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000068335.01620.9D"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1480"},{"key":"e_1_2_11_33_2","first-page":"518","article-title":"Renal insufficiency and failure associated with immune globulin intravenous therapy\u2014United States, 1985\u20131998","volume":"48","author":"Center for Disease Control and Prevention","year":"1999","journal-title":"Morbid Mortal Wkly Rep"},{"key":"e_1_2_11_34_2","first-page":"231","article-title":"Safety of therapeutic immune globulin preparations with respect to transmission of human T\u2010lymphotropic virus type III\/lymphadenopathy\u2010associated virus infection","volume":"35","author":"Center for Disease Control and Prevention","year":"1986","journal-title":"Morbid Mortal Wkly Rep"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90627-1"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(99)80064-2"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.1.94"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2004.09302.x"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(03)00010-8"},{"key":"e_1_2_11_40_2","first-page":"493","article-title":"Long\u2010term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin","volume":"88","author":"Choudhary PP","year":"1995","journal-title":"Q J Med"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00919601"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0934-5"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(02)00121-6"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0808-z"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308193290820"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-9-199705010-00008"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.2.223"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199911)22:11<1479::AID-MUS3>3.0.CO;2-B"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.04.002"},{"key":"e_1_2_11_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410090719"},{"key":"e_1_2_11_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400516"},{"key":"e_1_2_11_53_2","first-page":"A214","article-title":"A double\u2010blind, placebo\u2010controlled study of rituximab in patients with anti\u2010MAG antibody\u2010demyelinating polyneuropathy (A\u2010MAG\u2010DP)","volume":"68","author":"Dalakas MC","year":"2007","journal-title":"Neurology"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)08496-1"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006650812886"},{"key":"e_1_2_11_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(98)00266-5"},{"key":"e_1_2_11_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00049-0"},{"key":"e_1_2_11_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.7.778"},{"key":"e_1_2_11_59_2","first-page":"376","article-title":"Transient renal dysfunction in diabetic patients after IVIg therapy","volume":"232","author":"Donatini B","year":"1992","journal-title":"J Intern Med"},{"key":"e_1_2_11_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10400"},{"key":"e_1_2_11_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602203140801"},{"key":"e_1_2_11_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02109-7"},{"key":"e_1_2_11_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360607"},{"key":"e_1_2_11_64_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.8.1173"},{"key":"e_1_2_11_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410110205"},{"key":"e_1_2_11_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20086"},{"key":"e_1_2_11_67_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.1.77"},{"key":"e_1_2_11_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210013271416"},{"key":"e_1_2_11_69_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1256"},{"key":"e_1_2_11_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300312"},{"key":"e_1_2_11_71_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.2.573"},{"key":"e_1_2_11_72_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363120-00003"},{"key":"e_1_2_11_73_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M407309200"},{"key":"e_1_2_11_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.019232"},{"key":"e_1_2_11_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2007.07.005"},{"key":"e_1_2_11_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2005.10104.x"},{"key":"e_1_2_11_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240705"},{"key":"e_1_2_11_78_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6.1735"},{"key":"e_1_2_11_79_2","volume-title":"Goodman & Gilman's pharmacological basis of therapeutics","year":"2005"},{"key":"e_1_2_11_80_2","first-page":"A369","article-title":"Efficacy of interferon beta\u20101a in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"70","author":"Gorson K","year":"2008","journal-title":"Neurology"},{"key":"e_1_2_11_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.2.321"},{"key":"e_1_2_11_82_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000134676.05850.C0"},{"key":"e_1_2_11_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20664"},{"key":"e_1_2_11_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/00131402-200306000-00004"},{"key":"e_1_2_11_85_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.84"},{"key":"e_1_2_11_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1069"},{"key":"e_1_2_11_87_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.9.1699"},{"key":"e_1_2_11_88_2","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.30145"},{"key":"e_1_2_11_89_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.1.57"},{"key":"e_1_2_11_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.4.1055"},{"key":"e_1_2_11_91_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.4.1067"},{"key":"e_1_2_11_92_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.5.586"},{"key":"e_1_2_11_93_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196309192691201"},{"key":"e_1_2_11_94_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03741.x"},{"key":"e_1_2_11_95_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.076869"},{"key":"e_1_2_11_96_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7168.1291"},{"key":"e_1_2_11_97_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1088"},{"key":"e_1_2_11_98_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01278.x"},{"key":"e_1_2_11_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70329-0"},{"key":"e_1_2_11_100_2","first-page":"CD003280","article-title":"Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Hughes RA","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2005.01.029"},{"key":"e_1_2_11_102_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.10.2742.bloodjournal85102742"},{"key":"e_1_2_11_103_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.3.615"},{"key":"e_1_2_11_104_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427050-00003"},{"key":"e_1_2_11_105_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-41130"},{"key":"e_1_2_11_106_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000134606.50529.C7"},{"key":"e_1_2_11_107_2","first-page":"985","volume-title":"Clinical practice of transfusion medicine","author":"Kobayashi RH","year":"1995"},{"key":"e_1_2_11_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199709)20:9<1102::AID-MUS2>3.0.CO;2-C"},{"key":"e_1_2_11_109_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041347"},{"key":"e_1_2_11_110_2","first-page":"127","article-title":"The clinical usefulness of high\u2010dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy [in Japanese]","volume":"51","author":"Kubori T","year":"1999","journal-title":"No To Shinkei"},{"key":"e_1_2_11_111_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.6.1364"},{"key":"e_1_2_11_112_2","first-page":"301","article-title":"Peripheral neuropathy and anti\u2010MAG antibodies","volume":"3","author":"Latov N","year":"1988","journal-title":"Crit Rev Neurobiol"},{"key":"e_1_2_11_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2004.03.012"},{"key":"e_1_2_11_114_2","first-page":"A551","article-title":"Therapy of neuropathy associated with anti\u2010MAG IgM monoclonal gammopathy with Rituxan","volume":"52","author":"Latov N","year":"1999","journal-title":"Neurology"},{"key":"e_1_2_11_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90296-2"},{"key":"e_1_2_11_116_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.1.145"},{"key":"e_1_2_11_117_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.8.1701"},{"issue":"1","key":"e_1_2_11_118_2","first-page":"A491","article-title":"Rituximab is effective therapy for some patients with IgM kappa related polyneuropathy: a report of results in 8 patients","volume":"60","author":"Lewis RA","year":"2003","journal-title":"Neurology"},{"key":"e_1_2_11_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10310-X"},{"key":"e_1_2_11_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(95)00269-8"},{"key":"e_1_2_11_121_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.2.249"},{"key":"e_1_2_11_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2005.05.008"},{"key":"e_1_2_11_123_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2003.00687.x"},{"key":"e_1_2_11_124_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.2.185"},{"key":"e_1_2_11_125_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6631.1262-a"},{"key":"e_1_2_11_126_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390121"},{"key":"e_1_2_11_127_2","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.30156"},{"key":"e_1_2_11_128_2","doi-asserted-by":"publisher","DOI":"10.1086\/504811"},{"key":"e_1_2_11_129_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.2.197"},{"key":"e_1_2_11_130_2","first-page":"347","article-title":"Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature","volume":"98","author":"Mathy I","year":"1998","journal-title":"Acta Neurol Belg"},{"key":"e_1_2_11_131_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/110.6.1617"},{"key":"e_1_2_11_132_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-5101.2003.00701.x"},{"key":"e_1_2_11_133_2","first-page":"CD002062","article-title":"Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta MM","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_134_2","first-page":"CD003906","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta MM","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_135_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.445"},{"key":"e_1_2_11_136_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.5.1206"},{"key":"e_1_2_11_137_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199309040-00003"},{"key":"e_1_2_11_138_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1986.26486262753.x"},{"key":"e_1_2_11_139_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.62.4.388"},{"key":"e_1_2_11_140_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/15.3.564"},{"key":"e_1_2_11_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.07.006"},{"key":"e_1_2_11_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(01)00478-6"},{"key":"e_1_2_11_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.02.027"},{"key":"e_1_2_11_144_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.6.727"},{"key":"e_1_2_11_145_2","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1001\/jama.1990.03450240091046","article-title":"Intravenous immune globulin: prevention and treatment of disease","volume":"264","author":"National Institutes of Health Consensus Conference","year":"1990","journal-title":"JAMA"},{"key":"e_1_2_11_146_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-0131-3"},{"key":"e_1_2_11_147_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106063242305"},{"key":"e_1_2_11_148_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1989.tb136537.x"},{"key":"e_1_2_11_149_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.4.710"},{"issue":"15","key":"e_1_2_11_150_2","first-page":"S53","article-title":"Safety and side effects of i.v. immunoglobulin therapy","volume":"14","author":"Nydegger UE","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_11_151_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040226"},{"key":"e_1_2_11_152_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.2.403"},{"key":"e_1_2_11_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70844-X"},{"key":"e_1_2_11_154_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000277266.53449.8b"},{"key":"e_1_2_11_155_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200010)65:2<177::AID-AJH17>3.0.CO;2-K"},{"key":"e_1_2_11_156_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240113"},{"key":"e_1_2_11_157_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.4.485"},{"key":"e_1_2_11_158_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.11.2028"},{"key":"e_1_2_11_159_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(76)90213-6"},{"key":"e_1_2_11_160_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380815"},{"key":"e_1_2_11_161_2","first-page":"85","volume-title":"Peripheral neuropathy\u2014a practical approach to diagnosis and management","author":"Reid VA","year":"2001"},{"key":"e_1_2_11_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90806-E"},{"key":"e_1_2_11_163_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01615.x"},{"key":"e_1_2_11_164_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000201193.00382.b3"},{"key":"e_1_2_11_165_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10359"},{"key":"e_1_2_11_166_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41020264.x"},{"key":"e_1_2_11_167_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000098996.02934.86"},{"key":"e_1_2_11_168_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.1210"},{"key":"e_1_2_11_169_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000145706.04340.25"},{"key":"e_1_2_11_170_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390502"},{"key":"e_1_2_11_171_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.5.638"},{"key":"e_1_2_11_172_2","first-page":"35","article-title":"Adverse reactions after high\u2010dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature","volume":"78","author":"Schiavotto C","year":"1993","journal-title":"Haematologica"},{"key":"e_1_2_11_173_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412153312409"},{"key":"e_1_2_11_174_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.43.26473"},{"key":"e_1_2_11_175_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-4-199408150-00004"},{"key":"e_1_2_11_176_2","first-page":"326","article-title":"Fludarabine for IgM antibody\u2010mediated neuropathies","volume":"36","author":"Sherman WH","year":"1994","journal-title":"Ann Neurol"},{"key":"e_1_2_11_177_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10947"},{"key":"e_1_2_11_178_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.6.661"},{"key":"e_1_2_11_179_2","doi-asserted-by":"publisher","DOI":"10.1159\/000008040"},{"key":"e_1_2_11_180_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1993.00540020015010"},{"key":"e_1_2_11_181_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032588"},{"key":"e_1_2_11_182_2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.60.8_suppl_3.S2","article-title":"The pathogenesis of CIDP\u2014rationale for treatment with immunomodulatory agents","volume":"60","author":"Toyka KV","year":"2003","journal-title":"Neurology"},{"key":"e_1_2_11_183_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00478.x"},{"key":"e_1_2_11_184_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-2457(98)00070-4"},{"key":"e_1_2_11_185_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.60.8_suppl_3.S23"},{"key":"e_1_2_11_186_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.3.421"},{"key":"e_1_2_11_187_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.7.1518"},{"key":"e_1_2_11_188_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01466.x"},{"key":"e_1_2_11_189_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.6.993"},{"key":"e_1_2_11_190_2","first-page":"CD004429","article-title":"Intravenous immunoglobulin for multifocal motor neuropathy","author":"van Schaik I","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_191_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.59.3.248"},{"key":"e_1_2_11_192_2","first-page":"383","article-title":"Treatment of patients with chronic inflammatory demyelinating polyneuropathy","volume":"152","author":"van Doorn PA","year":"1996","journal-title":"Rev Neurol (Paris)"},{"key":"e_1_2_11_193_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530140113024"},{"key":"e_1_2_11_194_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70414-2"},{"key":"e_1_2_11_195_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.8.1636-a"},{"key":"e_1_2_11_196_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.1.127"},{"key":"e_1_2_11_197_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.118240"},{"key":"e_1_2_11_198_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000173031.56429.04"},{"key":"e_1_2_11_199_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh222"},{"key":"e_1_2_11_200_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2004000500031"},{"key":"e_1_2_11_201_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.250"},{"key":"e_1_2_11_202_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000140497.85952.FA"},{"key":"e_1_2_11_203_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002230001146"},{"key":"e_1_2_11_204_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<74::AID-JCA6>3.0.CO;2-O"},{"key":"e_1_2_11_205_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.5.575"},{"key":"e_1_2_11_206_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880170510"},{"key":"e_1_2_11_207_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200009)65:1<30::AID-AJH5>3.0.CO;2-J"},{"key":"e_1_2_11_208_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92511-0"},{"key":"e_1_2_11_209_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901213400311"},{"key":"e_1_2_11_210_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199507000-00008"},{"key":"e_1_2_11_211_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh127"},{"key":"e_1_2_11_212_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O"}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.21277","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.21277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T05:43:33Z","timestamp":1700027013000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.21277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,19]]},"references-count":211,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1002\/mus.21277"],"URL":"https:\/\/doi.org\/10.1002\/mus.21277","archive":["Portico"],"relation":{},"ISSN":["0148-639X","1097-4598"],"issn-type":[{"value":"0148-639X","type":"print"},{"value":"1097-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,19]]}}}